AGING

• Interrelationships among HDL metabolism, aging, and atherosclerosis.
  (Walter M. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1244-50. Epub 2009 Aug 10. Review.)
  View Abstract

• Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
  (Cui Y, et al. Am J Cardiol. 2009 Sep 15;104(6):829-34.)
  View Abstract
• Low high-density lipoprotein predicts death in patients with mild left ventricular dysfunction regardless of coronary atherosclerosis.
  (Sampietro T, et al. J Cardiovasc Med (Hagerstown). 2009 Sep 30. [Epub ahead of print])
  View Abstract

• Low level natural antibodies against phosphorylcholine: A novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
  (Frostegård J. Clin Immunol. 2009 Sep 10. [Epub ahead of print])
  View Abstract
• Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol.
  (Zha W, et al. Biomarkers. 2009 Sep;14(6):372-80.)
  View Abstract
• Retinol-binding protein 4 (RBP4): a biomarker for subclinical atherosclerosis?
  (Stuck BJ, et al. Am J Hypertens. 2009 Sep;22(9):948-9. No abstract available.)
  View Abstract
• Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts.
  (Rizvi AA. Am J Med Sci. 2009 Sep 1. [Epub ahead of print])
  View Abstract
• Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis.
  (Nguyen TT, et al. Diabetes Care. 2009 Sep;32(9):1704-9. Epub 2009 Jun 23.)
  View Abstract
• Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.
  (Wong ND, et al. JACC Cardiovasc Imaging. 2009 Sep;2(9):1093-9.)
  View Abstract

• Association of common carotid intimal medial thickness (CCA-IMT) with risk factors of atherosclerosis in patients with type 2 diabetes mellitus.
  (Butt MU, et al. J Pak Med Assoc. 2009 Sep;59(9):590-3.)
  View Abstract
• Are measures of height and leg length related to incident diabetes mellitus? The ARIC (Atherosclerosis Risk in Communities) study.
  (Weitzman S, et al. Acta Diabetol. 2009 Sep 23. [Epub ahead of print])
  View Abstract
• Reduced negative surface charge on arterial endothelium of diabetic patients may account for accelerated atherosclerosis: new evidence presented by Gustav Born.
  ([No authors listed] Eur Heart J. 2009 Sep;30(17):2068-70. No abstract available.)
  View Abstract

DIET, NUTRITION, AND METABOLISM

• A 'Desaturase Hypothesis' for Atherosclerosis: Janus-Faced Enzymes in omega-6 and omega-3 Polyunsaturated Fatty Acid Metabolism.
  (Martinelli N, et al. J Nutrigenet Nutrigenomics. 2009 Sep 23;2(3):129-139. [Epub ahead of print])
  View Abstract
• Effect of rapeseed oil-derived plant sterol and stanol esters on atherosclerosis parameters in cholesterol-challenged heterozygous Watanabe Heritable Hyperlipidaemic rabbits.
  (Schrøder M, et al. Br J Nutr. 2009 Sep 22:1-12. [Epub ahead of print])
  View Abstract
• Safflower seed polyphenols (N-(p-coumaroyl)serotonin and N-feruloylserotonin) ameliorate atherosclerosis and distensibility of the aortic wall in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.
  (Katsuda SI, et al. Hypertens Res. 2009 Sep 18. [Epub ahead of print])
  View Abstract
• Does eicosapentaenoic acid truly reduce atherosclerosis?
  (Ishikawa S, et al. Hypertens Res. 2009 Sep 18. [Epub ahead of print] No abstract available.)
  View Abstract
• Atherosclerosis regression study in rabbits upon olive pomace polar lipid extract administration.
  (Tsantila N, et al. Nutr Metab Cardiovasc Dis. 2009 Sep 10. [Epub ahead of print])
  View Abstract
• Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Bomback AS, et al. Am J Clin Nutr. 2009 Sep 9. [Epub ahead of print])
  View Abstract
• Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice.
  (Matsui T, et al. Br J Nutr. 2009 Sep 4:1-5. [Epub ahead of print])
  View Abstract
• Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.
  (Nettleton JA, et al. Am J Clin Nutr. 2009 Sep;90(3):647-54. Epub 2009 Jul 22.)
  View Abstract
• Vitamin E does not regress hypercholesterolemic atherosclerosis.
  (Prasad K. J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):231-41. Epub 2009 Jun 4.)
  View Abstract
• Extract from the Leaf of Nucifera Reduced the Development of Atherosclerosis via Inhibition of Vascular Smooth Muscle Cell Proliferation and Migration.
  (Ho HH, et al. Food Chem Toxicol. 2009 Sep 29. [Epub ahead of print])
  View Abstract
• Noninvasive methods for assessing early markers of atherosclerosis: the role of body composition and nutrition.
  (Stamatelopoulos K, et al. Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):467-73.)
  View Abstract

DRUG THERAPY

• A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.
  (Bertrand OF, et al. Can J Cardiol. 2009 Sep;25(9):509-15.)
  View Abstract
• Is gallium nitrate an effective kidney stone, calcified uterine fibroid, atherosclerosis and cataract anti-nanobacteria treatment? A case history and hypothesis.
  (Eby G. Med Hypotheses. 2009 Sep 14. [Epub ahead of print] No abstract available.)
  View Abstract
• Combination therapy for treatment or prevention of atherosclerosis: Focus on the lipid-RAAS interaction.
  (Koh KK, et al. Atherosclerosis. 2009 Sep 12. [Epub ahead of print])
  View Abstract
• Anacetrapib, a cholesterol ester transfer protein (CETP) inhibitor for the treatment of atherosclerosis.
  (Masson D. Curr Opin Investig Drugs. 2009 Sep;10(9):980-7.)
  View Abstract
• Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
  (Zanchetti A, et al. Circulation. 2009 Sep 22;120(12):1084-90. Epub 2009 Sep 8.)
  View Abstract
• Azelnidipine and Amlodipine Anti-Coronary Atherosclerosis Trial in Hypertensive Patients Undergoing Coronary Intervention by Serial Volumetric Intravascular Ultrasound Analysis in Juntendo University (ALPS-J).
  (Miyauchi K, et al. Cardiovasc Drugs Ther. 2009 Sep 18. [Epub ahead of print])
  View Abstract
• Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.
  (Rodés-Cabau J, et al. Am J Cardiol. 2009 Sep 15;104(6):750-7.)
  View Abstract
• Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of Atherosclerosis.
  (Delaney JA, et al. Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):826-32.)
  View Abstract
• SIRT1: a novel target to prevent atherosclerosis.
  (Yu W, et al. J Cell Biochem. 2009 Sep 1;108(1):10-3.)
  View Abstract

EPIDEMIOLOGY

• Atherosclerosis profile and incidence of cardiovascular events: a population-based survey.
  (Robinson JG, et al. BMC Cardiovasc Disord. 2009 Sep 15;9:46.)
  View Abstract
• Do socioeconomic gradients in subclinical atherosclerosis vary according to acculturation level? Analyses of Mexican-Americans in the multi-ethnic study of atherosclerosis.
  (Gallo LC, et al. Psychosom Med. 2009 Sep;71(7):756-62. Epub 2009 Aug 6.)
  View Abstract
• The relationship between social status and atherosclerosis in male and female monkeys as revealed by meta-analysis.
  (Kaplan JR, et al. Am J Primatol. 2009 Sep;71(9):732-41.)
  View Abstract The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Ding J, et al. Am J Clin Nutr. 2009 Sep;90(3):499-504. Epub 2009 Jul 1.)
  View Abstract

• Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis.
  (Ben Assayag E, et al. Thromb Res. 2009 Sep;124(4):458-62. Epub 2009 May 9.)
  View Abstract
• Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.
  (Chien KL, et al. Transl Res. 2009 Sep;154(3):133-41. Epub 2009 Jul 9.)
  View Abstract
• A role for MMP-3 genetic variation in atherosclerosis susceptibility?
  (Clee SM. Atherosclerosis. 2009 Sep 20. [Epub ahead of print] No abstract available.)
  View Abstract
• Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese.
  (Miwa Y, et al. Hypertens Res. 2009 Sep 18. [Epub ahead of print])
  View Abstract
• MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes.
  (Yuasa S, et al. Diabetes Res Clin Pract. 2009 Sep 23. [Epub ahead of print])
  View Abstract
  

HYPERTENSION

• Relationship between serum bilirubin and carotid atherosclerosis in hypertensive patients.
  (Yang XF, et al. Intern Med. 2009;48(18):1595-9. Epub 2009 Sep 15.)
  View Abstract
• Blood Glutathione and Subclinical Atherosclerosis in African Men: The SABPA Study.
  (Schutte R, et al. Am J Hypertens. 2009 Sep 3. [Epub ahead of print])
  View Abstract
  

IMAGING

• Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.
  (Haider N, et al. J Nucl Cardiol. 2009 Sep-Oct;16(5):753-62. Epub 2009 Aug 7.)
  View Abstract
• Ultrasound molecular imaging of atherosclerosis.
  (Kaufmann BA. Cardiovasc Res. 2009 Sep 1;83(4):617-25. Epub 2009 Jun 3.)
  View Abstract
• Carotid magnetic resonance imaging. A window to study atherosclerosis and identify high-risk plaques.
  (Oikawa M, et al. Circ J. 2009 Oct;73(10):1765-73. Epub 2009 Sep 15.)
  View Abstract
• Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography.
  (Seeger A, et al. Eur Radiol. 2009 Sep 16. [Epub ahead of print])
  View Abstract
• Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study.
  (Shaw LJ, et al. J Am Coll Cardiol. 2009 Sep 29;54(14):1258-67.)
  View Abstract
• Geometric and Compositional Appearance of Atheroma in an Angiographically Normal Carotid Artery in Patients with Atherosclerosis.
  (Dong L, et al. AJNR Am J Neuroradiol. 2009 Sep 24. [Epub ahead of print])
  View Abstract
• Noninvasive Assessment of Atherosclerosis in Patients with Isolated Hypertension.
  (Guntekin U, et al. Echocardiography. 2009 Sep 18. [Epub ahead of print])
  View Abstract
• Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography.
  (Lehrke S, et al. J Cardiovasc Magn Reson. 2009 Sep 17;11(1):36.)
  View Abstract
• Images in cardiovascular medicine: Microscopic computed tomography-based virtual histology for visualization and morphometry of atherosclerosis in diabetic apolipoprotein e mutant mice.
  (Martinez HG, et al. Circulation. 2009 Sep 1;120(9):821-2. No abstract available.)
  View Abstract
• Coronary calcium significantly affects quantitative analysis of coronary ultrasound: importance for atherosclerosis progression/regression studies.
  (Bruining N, et al. Coron Artery Dis. 2009 Sep;20(6):409-14.)
  View Abstract
• Atherosclerosis measured by whole body magnetic resonance angiography and carotid artery ultrasound is related to arterial compliance, but not to endothelium-dependent vasodilation - the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study.
  (Lind L, et al. Clin Physiol Funct Imaging. 2009 Sep;29(5):321-9. Epub 2009 May 20.)
  View Abstract
• Brachial artery hyperemic blood flow velocities are related to carotid atherosclerosis.
  (Järhult SJ, et al. Clin Physiol Funct Imaging. 2009 Sep;29(5):360-5. Epub 2009 Jun 8.)
  View Abstract
• Serial intravascular ultrasound assessment of atherosclerosis progression and regression. State-of-the-art and limitations.
  (Mintz GS, et al. Circ J. 2009 Sep;73(9):1557-60. Epub 2009 Jul 29.)
  View Abstract
• Comparison of degree of stenosis and plaque volume for the assessment of carotid atherosclerosis using 2-D ultrasound.
  (de Labriolle A, et al. Ultrasound Med Biol. 2009 Sep;35(9):1436-42. Epub 2009 Jun 26.)
  View Abstract

IMMUNOLOGY

• Antitreponemal antibodies leading to autoantibody production and protection from atherosclerosis in Kitavans from Papua New Guinea.
  (Agmon-Levin N, et al. Ann N Y Acad Sci. 2009 Sep;1173:675-82.)
  View Abstract
• The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
  (van Leeuwen M, et al. Ann N Y Acad Sci. 2009 Sep;1173:274-9.)
  View Abstract
• Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.
  (Damy SB, et al. BMC Microbiol. 2009 Sep 10;9:194.)
  View Abstract
• Innate immune signals in atherosclerosis.
  (Lundberg AM, et al. Clin Immunol. 2009 Sep 8. [Epub ahead of print])
  View Abstract
• Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis.
  (Taleb S, et al. J Exp Med. 2009 Sep 28;206(10):2067-77. Epub 2009 Sep 8.)
  View Abstract
• Human immunodeficiency virus and atherosclerosis.
  (Farrugia PM, et al. Cardiol Rev. 2009 Sep-Oct;17(5):211-5.)
  View Abstract
• The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
  (van Leeuwen M, et al. Autoimmun Rev. 2009 Sep;9(1):53-7. Epub 2009 Mar 11.)
  View Abstract
• Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.
  (Grunfeld C, et al. AIDS. 2009 Sep 10;23(14):1841-9.)
  View Abstract
• A Th2 immune shift to heat shock protein 65 fails to arrest atherosclerosis: Proatherogenic role of Th2-deviated autoantibodies.
  (Xiong Q, et al. Autoimmunity. 2009 Sep;42(6):475-83.)
  View Abstract
• Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.
  (Leung VW, et al. Am J Pathol. 2009 Oct;175(4):1757-67. Epub 2009 Sep 3.)
  View Abstract
• Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study.
  (Pertovaara M, et al. Rheumatology (Oxford). 2009 Sep 24. [Epub ahead of print])
  View Abstract

INFLAMMATION

• Increased left ventricular arrhythmogenicity in metabolic syndrome and relationship with myocardial performance, risk factors for atherosclerosis, and low-grade inflammation.
  (Voulgari C, et al. Metabolism. 2009 Sep 17. [Epub ahead of print])
  View Abstract
• Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis.
  (Ramesh E, et al. Chem Biol Interact. 2009 Sep 24. [Epub ahead of print])
  View Abstract

INNOVATIVE TECHNIQUES / MODELING

• FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
  (Davies JR, et al. Int J Cardiovasc Imaging. 2009 Sep 22. [Epub ahead of print])
  View Abstract
• The correspondence between coronary arterial wall strain and histology in a porcine model of atherosclerosis.
  (Liang Y, et al. Phys Med Biol. 2009 Sep 21;54(18):5625-41. Epub 2009 Sep 1.)
  View Abstract

LIFESTYLE

• Physical fitness and carotid atherosclerosis in men.
  (Lee CD, et al. Int J Sports Med. 2009 Sep;30(9):672-6. Epub 2009 Jun 30.)
  View Abstract

MENOPAUSE

• Double-blind placebo-controlled study to evaluate the effect of pro-juven progesterone cream on atherosclerosis and bone density.
  (Benster B, et al. Menopause Int. 2009 Sep;15(3):100-6.)
  View Abstract
• Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women.
  (Seo SK, et al. Menopause. 2009 Sep-Oct;16(5):937-43.)
  View Abstract

METABOLIC SYNDROME

• Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group.
  (Bang OY, et al. J Neurol Sci. 2009 Sep 15;284(1-2):40-5. Epub 2009 Apr 26.)
  View Abstract
• Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.
  (Escobedo J, et al. Cardiovasc Diabetol. 2009 Sep 26;8(1):52. [Epub ahead of print])
  View Abstract
• Metabolic Syndrome Is Associated with Increased Arterial Stiffness and Biomarkers of Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus.
  (Sabio JM, et al. J Rheumatol. 2009 Sep 1. [Epub ahead of print])
  View Abstract
• Abnormal liver function tests and metabolic syndrome--is fatty liver related to risks for atherosclerosis beyond obesity?
  (Sakurai M, et al. Intern Med. 2009;48(18):1573-4. Epub 2009 Sep 15. No abstract available.)
  View Abstract
• Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.
  (Zanetti M, et al. Clin Exp Med. 2009 Sep;9(3):243-8. Epub 2009 Feb 24.)
  View Abstract

• Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation.
  (Shively CA, et al. Am J Primatol. 2009 Sep;71(9):742-51.)
  View Abstract

• Particulate matter and atherosclerosis: role of particle size, composition and oxidative stress.
  (Araujo JA, et al. Part Fibre Toxicol. 2009 Sep 18;6(1):24. [Epub ahead of print])
  View Abstract
• Roles of Oxidative Stress and Redox Regulation in Atherosclerosis.
  (Kondo T, et al. J Atheroscler Thromb. 2009 Sep 14. [Epub ahead of print])
  View Abstract
• The role of oxidative stress in atherosclerosis.
  (Vogiatzi G, et al. Hellenic J Cardiol. 2009 Sep-Oct;50(5):402-9. No abstract available.)
  View Abstract

PEDIATRICS

• Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents. Recommendations for Standard Assessment for Clinical Research. A Scientific Statement From the American Heart Association.
  (Urbina EM, et al. Hypertension. 2009 Sep 3. [Epub ahead of print])
  View Abstract

PLAQUE BIOLOGY

• Absence of Akt1 Reduces Vascular Smooth Muscle Cell Migration and Survival and Induces Features of Plaque Vulnerability and Cardiac Dysfunction During Atherosclerosis.
  (Fernández-Hernando C, et al. Arterioscler Thromb Vasc Biol. 2009 Sep 17. [Epub ahead of print])
  View Abstract
• Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques.
  (Lavi S, et al. Heart. 2009 Sep;95(18):1525-30. Epub 2009 Jun 3.)
  View Abstract

RENAL DISEASE

• Zinc deficiency in Chronic Kidney Disease: Is there a Relationship with Adipose Tissue and Atherosclerosis?
  (Lobo JC, et al. Biol Trace Elem Res. 2009 Sep 4. [Epub ahead of print])
  View Abstract

RISK FACTORS

• Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players.
  (Chang AY, et al. Am J Cardiol. 2009 Sep 15;104(6):805-11. Epub 2009 Jul 18.)
  View Abstract
• Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study.
  (Jylhävä J, et al. J Intern Med. 2009 Sep;266(3):286-95.)
  View Abstract
• Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance.
  (Messner B, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1392-8. Epub 2009 Jun 25.)
  View Abstract
• Retinol-binding protein 4 & atherosclerosis: risk factor or innocent bystander?
  (von Eynatten M, et al. Atherosclerosis. 2009 Sep;206(1):38-9. Epub 2009 May 6. No abstract available.)
  View Abstract
• MMP-1 serum levels predict coronary atherosclerosis in humans.
  (Lehrke M, et al. Cardiovasc Diabetol. 2009 Sep 14;8:50.)
  View Abstract
• The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis.
  (McNeely MJ, et al. Diabetes Care. 2009 Sep;32(9):1727-33. Epub 2009 Jun 23.)
  View Abstract
• Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.
  (Lederer DJ, et al. Am J Respir Crit Care Med. 2009 Sep 1;180(5):407-14. Epub 2009 Jun 19.)
  View Abstract

STROKE

• Pitfalls in meta-analysis of observational studies: lessons from a systematic review of the risks of stenting for intracranial atherosclerosis.
  (Trinquart L, et al. Stroke. 2009 Oct;40(10):e586-7; author reply e590. Epub 2009 Sep 10. No abstract available.)
  View Abstract

THROMBOSIS / HAEMOSTATIS

• Studies of mice lacking the GPIb-V-IX complex question the role of this receptor in atherosclerosis.
  (Strassel C, et al. J Thromb Haemost. 2009 Sep 9. [Epub ahead of print] No abstract available.)
  View Abstract

VASCULAR BIOLOGY

• Heparin Cofactor II as a Novel Vascular Protective Factor Against Atherosclerosis.
  (Aihara KI, et al. J Atheroscler Thromb. 2009 Sep 3. [Epub ahead of print])
  View Abstract
• Metabolism and actions of conjugated linoleic acids on atherosclerosis-related events in vascular endothelial cells and smooth muscle cells.
  (Eder K, et al. Mol Nutr Food Res. 2009 Sep 16. [Epub ahead of print])
  View Abstract
• Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis.
  (Kerekes G, et al. Ann N Y Acad Sci. 2009 Sep;1173:814-21.)
  View Abstract
• Subclinical atherosclerosis in association with elevated placental vascular resistance in early pregnancy.
  (Lausman AY, et al. Atherosclerosis. 2009 Sep;206(1):33-5. Epub 2009 Feb 20. No abstract available.)
  View Abstract
• Role of Rho/Rho-Kinase and NO/cGMP Signaling Pathways in Vascular Function Prior to Atherosclerosis.
  (Mori-Kawabe M, et al. J Atheroscler Thromb. 2009 Sep 16. [Epub ahead of print])
  View Abstract
• MicroRNA and vascular smooth muscle cell phenotype: new therapy for atherosclerosis?
  (Zhang C. Genome Med. 2009 Sep 9;1(9):85. [Epub ahead of print])
  View Abstract
• Increased Levels of Osteocalcin-Positive Endothelial Progenitor Cells in Patients Affected by Erectile Dysfunction and Cavernous Atherosclerosis.
  (Foresta C, et al. J Sex Med. 2009 Sep 30. [Epub ahead of print])
  View Abstract
• Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: A possible link between the nervous system and atherosclerosis development.
  (Wilund KR, et al. Biochem Biophys Res Commun. 2009 Sep 26. [Epub ahead of print])
  View Abstract
• Fn14-Fc Fusion Protein Regulates Atherosclerosis in ApoE-/- Mice and Inhibits Macrophage Lipid Uptake In Vitro.
  (Schapira K, et al. Arterioscler Thromb Vasc Biol. 2009 Sep 17. [Epub ahead of print])
  View Abstract
• Macrophage apoptosis in advanced atherosclerosis.
  (Tabas I, et al. Ann N Y Acad Sci. 2009 Sep;1173 Suppl 1:E40-5.)
  View Abstract
• Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
  (Rau JC, et al. Exp Mol Pathol. 2009 Sep 9. [Epub ahead of print])
  View Abstract
• A Role of Matrix Metalloproteinase-8 in Atherosclerosis.
  (Laxton RC, et al. Circ Res. 2009 Sep 10. [Epub ahead of print])
  View Abstract
• PPARgamma1-Induced Caveolin-1 Enhances Cholesterol Efflux and Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
  (Hu Q, et al. J Vasc Res. 2009 Sep 3;47(1):69-79. [Epub ahead of print])
  View Abstract
• Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis.
  (Sekiya M, et al. Cell Metab. 2009 Sep;10(3):219-28.)
  View Abstract
• Age, increased left ventricular mass, and lower regional myocardial perfusion are related to greater extent of myocardial dyssynchrony in asymptomatic individuals: the multi-ethnic study of atherosclerosis.
  (Rosen BD, et al. Circulation. 2009 Sep 8;120(10):859-66. Epub 2009 Aug 24.)
  View Abstract
• Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
  (Zhang LN, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1265-70. Epub 2009 Aug 10.)
  View Abstract
• Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis.
  (Gordts PL, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1258-64. Epub 2009 Aug 10.)
  View Abstract
• Increased plasma levels of plant sterols and atherosclerosis: a controversial issue.
  (Calpe-Berdiel L, et al. Curr Atheroscler Rep. 2009 Sep;11(5):391-8.)
  View Abstract
• 17beta-Estradiol Prevents Early-Stage Atherosclerosis in Estrogen Receptor-Alpha Deficient Female Mice.
  (Villablanca AC, et al. J Cardiovasc Transl Res. 2009 Sep;2(3):289-299. Epub 2009 May 2.)
  View Abstract
• Association of salivary cortisol circadian pattern with cynical hostility: multi-ethnic study of atherosclerosis.
  (Ranjit N, et al. Psychosom Med. 2009 Sep;71(7):748-55. Epub 2009 Jul 10.)
  View Abstract
• Effects of oral estrogen on aortic ROS-generating and -scavenging enzymes and atherosclerosis in apoE-deficient mice.
  (Wing LY, et al. Exp Biol Med (Maywood). 2009 Sep;234(9):1037-46. Epub 2009 Jun 22.)
  View Abstract
• ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis.
  (Meyer MR, et al. Cardiovasc Res. 2009 Sep 1;83(4):605-10. Epub 2009 Jun 18. No abstract available.)
  View Abstract
• Intake of dissolved organic matter from deep seawater inhibits atherosclerosis progression.
  (Radhakrishnan G, et al. Biochem Biophys Res Commun. 2009 Sep 11;387(1):25-30. Epub 2009 Jun 18.)
  View Abstract
• Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
  (Zhao Y, et al. Arterioscler Thromb Vasc Biol. 2009 Sep;29(9):1349-55. Epub 2009 Jun 11.)
  View Abstract
• Molecular role of Cx37 in advanced atherosclerosis: a micro-array study.
  (Derouette JP, et al. Atherosclerosis. 2009 Sep;206(1):69-76. Epub 2009 Feb 27.)
  View Abstract
• Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice.
  (de Vries-van der Weij J, et al. Atherosclerosis. 2009 Sep;206(1):153-8. Epub 2009 Mar 19.)
  View Abstract
• Carotid arterial elasticity is a sensitive atherosclerosis value reflecting visceral fat accumulation in obese subjects.
  (Tokita A, et al. Atherosclerosis. 2009 Sep;206(1):168-72. Epub 2009 Feb 20.)
  View Abstract
• Human coronary atherosclerosis modulates cardiac natriuretic peptide release.
  (Barbato E, et al. Atherosclerosis. 2009 Sep;206(1):258-64. Epub 2009 Feb 3.)
  View Abstract
• Epigenetics and atherosclerosis.
  (Turunen MP, et al. Biochim Biophys Acta. 2009 Sep;1790(9):886-91. Epub 2009 Feb 21. Review.)
  View Abstract

• Calcification in atherosclerosis.
  (Alexopoulos N, et al. Nat Rev Cardiol. 2009 Sep 29. [Epub ahead of print])
  View Abstract
• Ethnic-specific risks for atherosclerotic calcification of the thoracic and abdominal aorta (from the Multi-Ethnic Study of Atherosclerosis).
  (Allison MA, et al. Am J Cardiol. 2009 Sep 15;104(6):812-7.)
  View Abstract
• Association of Kidney Function With Coronary Atherosclerosis and Calcification in Autopsy Samples From Japanese Elders: The Hisayama Study.
  (Nakano T, et al. Am J Kidney Dis. 2009 Sep 16. [Epub ahead of print])
  View Abstract
• Relationship between common carotid intima-media thickness and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.
  (Takasu J, et al. Atherosclerosis. 2009 Sep 15. [Epub ahead of print])
  View Abstract

The following articles were recommended by Eder Quintão, MD

• Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.
  (Rodés-Cabau J, et al. Am J Cardiol. 2009 Sep 15;104(6):750-7.)
  View Abstract
• Estrogen decreases atherosclerosis in part by reducing hepatic acyl-CoA:cholesterol acyltransferase 2 (ACAT2) in monkeys.
  (Kavanagh K, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1471-7.)
  View Abstract
• Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice.
  (Kennedy DJ, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1481-7. Epub 2009 Jul 16.)
  View Abstract
• Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.
  (Lalloyer F, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1488-95. Epub 2009 Jul 10.)
  View Abstract
• Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano.
  (Alexander ET, et al. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1496-501. Epub 2009 Aug 6.)
  View Abstract
• Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.
  (Wiersma H, et al. Atherosclerosis. 2009 Sep;206(1):141-7. Epub 2009 Mar 11.)
  View Abstract
• Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression.
  (Iacobazzi V, et al. Biochem Biophys Res Commun. 2009 Oct 30;388(4):643-7. Epub 2009 Aug 6.)
  View Abstract
• Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolism.
  (van Haperen R, et al. Biochim Biophys Acta. 2009 Oct;1791(10):1031-6. Epub 2009 Jun 11.)
  View Abstract
• Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis.
  Sekiya M, Osuga J, Nagashima S, Ohshiro T, Igarashi M, Okazaki H, Takahashi M, (Tazoe F, et al. Cell Metab. 2009 Sep;10(3):219-28.)
  View Abstract
• Bile acids: regulation of synthesis.
  (Chiang JY. J Lipid Res. 2009 Apr 3. [Epub ahead of print])
  View Abstract
• Activation of pregnane X receptor induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apolipoprotein E deficient mice.
  (Zhou C, et al. J Lipid Res. 2009 May 12. [Epub ahead of print])
  View Abstract
• Triglyceride alters lysosomal cholesterol metabolism in cholesteryl ester-laden macrophage foam cells.
  (Ullery-Ricewick JC, et al. J Lipid Res. 2009 May 21. [Epub ahead of print])
  View Abstract
• PPARd activation leads to increased trans intestinal cholesterol efflux.
  (Vrins CL, et al. J Lipid Res. 2009 May 13. [Epub ahead of print])
  View Abstract
• Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men.
  (Sudhop T, et al. J Lipid Res. 2009 Apr 20. [Epub ahead of print])
  View Abstract
• ABC transporters: a riddle wrapped in a mystery inside an enigma.
  (Jones PM, et al. Trends Biochem Sci. 2009 Oct;34(10):520-31. Epub 2009 Sep 11.)
  View Abstract